Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI ...

Adults with moderate to severe hidradenitis suppurativa experienced substantial long-term symptom relief and quality of life ...

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI 100 (41.0%, 39.5%)Quality‑of‑life improvements and itch ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

Spring breakers and summer vacationers, pack some extra bug spray. The CDC updated warnings for travelers this week, ...

Coconino County health officials are trying to determine who may have been exposed after another resident has tested positive ...

“You’re having a belly button period,” a doctor friend texted me. Truly, a sentence no one wants to hear. But it wasn’t so simple.

According to the Utah Department of Health and Human Services (DHHS), the state now has 486 cases. ABC4 has compiled a list ...

Symptom control throughout three years: 86.1% of people living with moderate-to-severe hidradenitis suppurativa (HS) treated with BIMZELX had no acute exacerbation of symptoms, known as ...

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression ...

Juries in two big cases have affirmed what research is finding: The design of social media platforms is particularly ...